All In Biotech

Drug Trial Radar · NCT04411082

A Study of IMR-687 in Subjects With Beta Thalassemia

A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects With Beta Thalassemia

Last checked: Nov 20, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

122

Actual

Start

Oct 16, 2020

Primary completion

Mar 11, 2022

Study completion May 4, 2022

Sponsor

Sponsor type
Industry
Collaborators
Imara, Inc.
First posted
Jun 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta Thalassemia

Conditions

  • β Thalassemia

Interventions

  • IMR-687Drug

    Oral administration of once daily IMR-687

  • PlaceboDrug

    Oral administration of once daily Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. IMR-687 Safety and TolerabilityTime frame: Baseline to Week 40

Locations

36 sites in 13 countries. Site status is shown where the registry gives one.

  • Herlev Hospital

    Herlev, Capital Region, Denmark

  • Hôpital Necker-Enfants Malades

    Paris, France

  • Institut Universitaire du Cancer de Toulouse Oncopole

    Toulouse, Haute-Garonn, France

  • Hôpital Edouard Herriot

    Lyon, Rhone, France

  • National Center of Surgery

    Tbilisi, Georgia

  • Medinvest - Institute of Hematology and Transfusiology

    Tbilisi, Georgia

  • M. Zodelava Hematology Centre

    Tbilisi, Borjomi, Georgia

  • Aghia Sofia General Children's Hospital

    Athens, Attica, Greece

  • Laiko General Hospital of Athens

    Athens, Attica, Greece

  • Ippokrateio General Hospital of Thessaloniki

    Thessaloniki, Central Macedonia, Greece

  • University General Hospital of Patras

    Patra, Peloponnese, Greece

  • Emek Medical Center

    Afula, Israel

  • Rambam Health Care Campus

    Haifa, Haifa District, Israel

  • Hadassah University Hospital Ein Kerem

    Jerusalem, Jerusalem, Israel

  • The Galilee Medical Center

    Nahariya, Northern District, Israel

  • Azienda Ospedaliera Giuseppe Brotzu

    Orbassano, Turin, Italy

  • Azienda Ospedaliera Universitaria - Università degli Studi della Campania Luigi Vanvitelli

    Orbassano, Turin, Italy

  • Chronic Care Center

    Hazmiyeh, Lebanon

  • Hospital Sultanah Aminah Johor Bharu

    Johor Bahru, Johor, Malaysia

  • Hospital Sultanah Bahiyah

    Alor Star, Kedah, Malaysia

  • Hospital Raja Permaisuri Bainun

    Ipoh, Perak, Malaysia

  • Hospital Pulau Pinang

    George Town, Pulau Pinang, Malaysia

  • Hospital Queen Elizabeth - Kota Kinabalu

    Kota Kinabalu, Sabah, Malaysia

  • Hospital Umum Sarawak

    Kuching, Sarawak, Malaysia

  • Hôpital d'Enfants Rabat

    Rabat, Morocco

  • Amsterdam Universitair Medische Centra - Academisch Medisch Centrum

    Amsterdam, North Holland, Netherlands

  • Centre Hôpital Universitaire Farhat Hached

    Sousse, Tunisia

  • Centre National de Greffe de la Moelle Osseuse

    Tunis, Tunisia

  • Hospital Aziza Othmana

    Tunis, Tunisia

  • Hacettepe Üniversitesi

    Ankara, Turkey (Türkiye)

  • Ege Universitesi Tip Fakultesi

    Izmir, Turkey (Türkiye)

  • Akdeniz Üniversitesi

    Mersin, Mersin, Turkey (Türkiye)

  • Mersin Üniversitesi Tıp Fakültesi

    Mersin, Mersin, Turkey (Türkiye)

  • Whittington Health NHS Trust

    London, England, United Kingdom

  • University College London Hospitals NHS Foundation Trust

    London, England, United Kingdom

  • Manchester University NHS Foundation Trust

    Manchester, England, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.